Publications
Data updated: 20.10.2026 14:29 · Number of records: 28 Clear filters
| Publication year / Category | Publication |
|---|
2025
V2 | Konflikty vo farmácii, príležitosti a výzvy Martin Višňanský, Štefania Laca Megyesi Dialóg o mediácii. Inšpirácia pre riešenie konfliktov |
2024
V3 | Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective Beáta Bušányová, Marie Vajter, Silvie Kelifová, Petra Lišková, Hedviga Miková, Katarína Breciková, Ján Žigmond, Vladimír Rogalewicz, Aleš Tichopád, Martin Višňanský, Ivana Šarkanová HeliyonIF 3.4IF5 3.9SJR Q 1JCR Q 2SJR 0.627ABDC 0.613Metrics year 2024 |
2024
V3 | Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective Marko Hawlina, Lea Kovač, Katarína Breciková, Ján Žigmond, Vladimír Rogalewicz, Aleš Tichopád, Martin Višňanský, Ivana Šarkanová Orphanet journal of rare diseasesIF 3.5IF5 4SJR Q 1JCR Q 2SJR 1.269ABDC 1.28Metrics year 2024 |
2024
V3 | The checklist for standard methodological requirements and reporting of economic evaluation of medicines in Slovakia Mária Bucek Pšenková, Lucia Hlavinková, Martin Višňanský, Dominik Grega, Martina Ondrušová Value in Health Regional IssuesIF 1.5IF5 1.7SJR Q 1JCR Q 3SJR 0.626ABDC 0.507Metrics year 2024 |
2022
V3 | Average CET limit: Is it possible to introduce a single CET for the whole EEA? Dominik Grega, Jozef Kolář, Martin Višňanský Value In HealthIF 4.5IF5 6.2SJR Q 1JCR Q 1SJR 1.414H-index 124ABDC 2.094Metrics year 2022 |
2020
BCI | Manažment pre študentov farmácie Jana Korimová, Martin Višňanský |
2020
BCI | Základy práva pre študentov farmácie Peter Korim, Monika Fedorová, Martin Višňanský rec. Jaroslav Legáth, Tomáš Wolaschka |
2019
AFD | Financovanie inovatívnych medicínskych technológií Martin Višňanský Škola - Veda - Prax, 17.-18. september 2019, Košice |
2018
ADF | Hodnotenie hodnotení - lieky (2016-2017) Martin Višňanský Farmakoekonomika a lieková politika |
2018
AFG | Impact of the international reference pricing on access to standard therapy drugs for copd Martin Višňanský, Anna Butalová Value In HealthIF 5.037IF5 6.131SJR Q 1JCR Q 1SJR 1.836H-index 97ABDC 2.082Metrics year 2018 |
2018
AFG | Is transparency in slovak hta efficient enought? Comparing pharmacoeconomics methodologies used in pricing & reimbursement applications for innovative therapies towards requirements defined by the law Martin Višňanský Value In HealthIF 5.037IF5 6.131SJR Q 1JCR Q 1SJR 1.836H-index 97ABDC 2.082Metrics year 2018 |
2017
ADF | Hodnotenie zdravotníckych technológií a hodnota za peniaze v liekovej politike Martin Višňanský, Radoslav Suchovič Onkológia |
2017
ADF | Inovácie vo farmaceutickom priemysle EÚ - dopad na rozpočet SR Martin Višňanský Farmakoekonomika a lieková politika |
2017
ADM | The Drug Policy in Central European Countries - Slovakia Mária Bucek Pšenková, Martin Višňanský, Stanislava Mackovičová, Dominik Tomek Value in Health Regional IssuesSJR Q 2SJR 0.366H-index 15Metrics year 2017 |
2016
ADF | HTA a personalizovaná medicína Martin Višňanský Farmakoekonomika a lieková politika |
2016
AFG | Impact of the international reference pricing on access to standard therapy drugs for asthma and COPD Martin Višňanský, Diana Kababiková Value In HealthIF 3.824IF5 4.491SJR Q 1JCR Q 1SJR 1.908H-index 97ABDC 1.63Metrics year 2016 |
2016
AFG | International Reference pricing across EU Martin Višňanský Value In HealthIF 3.824IF5 4.491SJR Q 1JCR Q 1SJR 1.908H-index 97ABDC 1.63Metrics year 2016 |
2015
AFG | A Novel Method for Calculating Medication Adherence to Poly-Pharmacotherapy by Linking General Practice Prescribing Data and Pharmacy Dispensing Records Tamás Ágh, András Inotai, László Szilberhorn, Josip Culig, Martin Višňanský, Zoltán Kaló, Guenka Petrova Value In HealthIF 3.824IF5 3.761SJR Q 1JCR Q 1SJR 1.736H-index 97ABDC 1.352Metrics year 2015 |
2015
ADF | Vývoj hodnotenia zdravotníckych technológií v Európe Martin Višňanský Farmakoekonomika a lieková politika |
2013
BAA | Clinical Guidelines for Chronic Conditions in the European Union Helena Legido-Quigley, Dimitra Panteli, Josip Car, Martin McKee, Reinhard Busse |
